BusinessAgile Therapeutics to Present at the Cantor Fitzgerald Global Healthcare ConferenceBy Nasdaq OMXSep 14, 2017, 11:45 AM UTC
BusinessAgile Therapeutics to Present Additional Phase 3 Data at the 73rd Annual Congress of the American Society for Reproductive MedicineBy Nasdaq OMXSep 7, 2017, 11:50 AM UTC
BusinessAgile Therapeutics Announces a Poster Presentation of its SECURE Phase 3 Study at the Contraceptive Technology 2017 ConferenceBy Nasdaq OMXMar 16, 2017, 8:30 PM UTC
